AMRX Amneal Pharmaceuticals, Inc.
Pharmaceutical Preparations · Nasdaq · SEC EDGAR official
Market Value*
$1.70B
Revenue (FY)
$3.02B 2025-12-31
Net Income (FY)
$72.06M
P/E (float-based)
23.6
American publicly traded generics and specialty pharmaceutical company.